A 52-year-old man with metastatic adenocarcinoma of the pancreas presents with acute dyspnea, chest pain, and hemoptysis. He has a blood pressure of 88/54 mmHg, heart rate 118/min, and respiratory rate 28/min. Laboratory investigations reveal: Hb 8.5 g/dL, WBC 12,000/μL, platelets 45,000/μL, PT 22 seconds (control 12), aPTT 68 seconds (control 36), fibrinogen 120 mg/dL, D-dimer 8.2 μg/mL, and LDH 680 U/L. A peripheral blood smear shows schistocytes. What is the primary mechanism responsible for the coagulopathy in this patient?

Explanation

## Mechanism of DIC in Solid Malignancies ### Pathophysiology of DIC DIC is a systemic thrombohemorrhagic disorder characterized by **uncontrolled activation of coagulation** leading to: 1. **Widespread fibrin deposition** in microvasculature 2. **Consumption** of platelets, fibrinogen, and clotting factors 3. **Secondary fibrinolysis** with plasmin-mediated degradation 4. **Microangiopathic hemolytic anemia** (schistocytes on smear) ### Trigger in Solid Malignancies Malignant cells (especially adenocarcinomas) release: - **Tissue factor (TF)** — initiates extrinsic pathway - **Cancer procoagulant** — directly activates Factor X - **Phosphatidylserine-expressing microvesicles** — amplify coagulation These bypass normal anticoagulant regulation, causing: ```mermaid flowchart TD A[Malignant cell TF release]:::action --> B[Extrinsic pathway activation]:::action B --> C[Thrombin generation]:::action C --> D[Fibrin deposition in microvasculature]:::outcome D --> E[Platelet + Factor consumption]:::outcome E --> F[Thrombocytopenia + Coagulopathy]:::outcome C --> G[Plasmin activation]:::action G --> H[Fibrinolysis]:::action H --> I[Elevated D-dimer + Low fibrinogen]:::outcome D --> J[RBC fragmentation]:::outcome J --> K[Schistocytes + Hemolysis]:::outcome ``` ### Laboratory Pattern in This Case | Finding | Mechanism | Interpretation | |---------|-----------|----------------| | Platelets 45,000 | Consumption in microthrombi | Thrombocytopenia | | PT 22 sec, aPTT 68 sec | Factor II, V, VII, X, XII consumed | Coagulopathy | | Fibrinogen 120 (low) | Consumption + fibrinolysis | Active DIC | | D-dimer 8.2 (very high) | Plasmin-mediated fibrin breakdown | Secondary fibrinolysis | | Schistocytes on smear | Mechanical fragmentation by fibrin strands | Microangiopathic hemolysis | | LDH 680 (elevated) | Hemolysis marker | Confirms MAHA | **Key Point:** The **combination of thrombocytopenia + coagulopathy + hypofibrinogenemia + elevated D-dimer + schistocytes** is the diagnostic hallmark of DIC. All findings point to **consumption coagulopathy**, not synthetic failure or immune destruction. **High-Yield:** Adenocarcinomas (pancreas, lung, breast, colon) are the solid tumors most commonly associated with DIC. The mechanism is TF-mediated extrinsic pathway activation. **Clinical Pearl:** The acute presentation (dyspnea, hemoptysis, hypotension) reflects **pulmonary microthrombi** with secondary hemorrhage. This is a medical emergency requiring: - Immediate anticoagulation (unfractionated heparin) - Transfusion support (platelets, FFP, cryoprecipitate) - Treatment of underlying malignancy